Showing results (151-160 of 191) with videos related to

Sort By:
Pageof 20
Signal Transduction and Targeted Therapy|January 23, 2025
VCP downstream metabolite glycerol-3-phosphate (G3P) inhibits CD8+T cells function in the HCC microenvironmentCheng Cheng, Qingrui Zha, Linmao Sun, et al.
Cancer Research|November 26, 2024
Chromatin Helicase CHD6 Establishes Proinflammatory Enhancers and Is a Synthetic Lethal Target in FH-Deficient Renal Cell CarcinomaJuan Jin, Jun Luo, Xiaodong Jin, et al.
Cancer Letters|March 8, 2020
Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasisKosuke Ogawa, Qiushi Lin, Le Li, et al.
Cell Death & Disease|March 1, 2019
miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1Jihua Han, Meiyin Zhang, Chunlei Nie, et al.
Cancer Letters|December 4, 2018
Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinomaRuiqi Liu, Yuejin Li, Lantian Tian, et al.
Journal of Hematology & Oncology|January 1, 2020
Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathwayKosuke Ogawa, Qiushi Lin, Le Li, et al.
Cellular & Molecular Immunology|April 13, 2026
MAIT cell plasticity generates CD4+ MAIT cells that promote HCC progression via metabolic crosstalk with tumor cellsSicheng Fu, Maoyu Tang, Changfeng Zhao, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 6, 2018
Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signalingYan Wang, Yingjian Liang, Guangchao Yang, et al.
Cell Reports. Medicine|April 17, 2026
A pig model of human radiation-induced veno-occlusive liver disease reveals ferroptosis as a therapeutic targetZhen Sun, Xinjie Zhang, Qiang Zheng, et al.
Hepatology (Baltimore, Md.)|August 18, 2016
N-myc downstream-regulated gene 2 inhibits human cholangiocarcinoma progression and is regulated by leukemia inhibitory factor/MicroRNA-181c negative feedback pathwayJiabei Wang, Changming Xie, Shangha Pan, et al.
Pageof 20